Children ages five to eleven years old could soon be rolling up their sleeves for Pfizer’s COVID-19 vaccine. But will the state be ready to administer those vaccines if the drugmaker is granted Emergency Use Authorization for this age group?
Infectious disease expert Dr. Wesley Willeford said with the rate of transmission, it is possible to have a safe holiday season this year. He said as long as your trick or treating plans are outside, you’ll likely be fine.
Jackson Hospital has partnered with the Alabama Department of Public Health and the U.S. Department of Health and Human Services to expand access to monoclonal antibody treatments at its main location.
On Thursday and Friday, the Food and Drug Administration convenes its independent advisers for the first stage in the process of deciding whether extra doses of the two vaccines should be dispensed and, if so, who should get them and when. The final go-ahead is not expected for at least another week.
If cleared by the Food and Drug Administration — a decision that could come in a matter of weeks — it would be the first pill shown to treat the illness. All other FDA-backed treatments against COVID-19 require an IV or injection.
AstraZeneca, the Anglo-Swedish drugmaker that developed one of the first COVID-19 vaccines, has asked the U.S. Food and Drug Administration to authorize the emergency use of an antibody treatment to prevent the disease.
The clock is ticking for a River Region pharmacy before hundreds of their COVID-19 vaccines go to waste. Parks Pharmacy in Montgomery has its refrigerator stocked with 900 Johnson & Johnson doses that expire on Saturday.